Mitsubishi UFJ Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309M Buy
5,092,003
+333,373
+7% +$19.4M 0.21% 92
2025
Q4
$254M Buy
4,758,630
+233,927
+5% +$11.3M 0.17% 109
2025
Q3
$204M Buy
4,524,703
+267,672
+6% +$12.5M 0.15% 125
2025
Q2
$197M Buy
4,257,031
+340,591
+9% +$16.7M 0.16% 121
2025
Q1
$239M Buy
3,916,440
+449,946
+13% +$26.2M 0.22% 98
2024
Q4
$196M Buy
3,466,494
+266,279
+8% +$14.9M 0.19% 106
2024
Q3
$166M Buy
3,200,215
+298,995
+10% +$14M 0.18% 112
2024
Q2
$120M Buy
2,901,220
+324,042
+13% +$14.5M 0.15% 126
2024
Q1
$140M Buy
2,577,178
+510,023
+25% +$26M 0.19% 100
2023
Q4
$108M Buy
2,067,155
+100,689
+5% +$5.29M 0.19% 103
2023
Q3
$114M Buy
1,966,466
+149,777
+8% +$9.18M 0.23% 87
2023
Q2
$116M Buy
1,816,689
+116,285
+7% +$7.8M 0.24% 82
2023
Q1
$118M Buy
1,700,404
+167,037
+11% +$11.8M 0.28% 75
2022
Q4
$111M Buy
1,533,367
+173,673
+13% +$13.1M 0.3% 72
2022
Q3
$96.7M Buy
1,359,694
+117,939
+9% +$8.56M 0.31% 64
2022
Q2
$95.6M Buy
1,241,755
+81,318
+7% +$6.19M 0.42% 46
2022
Q1
$84.7M Buy
1,160,437
+89,243
+8% +$5.99M 0.33% 62
2021
Q4
$66.3M Buy
1,071,194
+145,476
+16% +$8.53M 0.26% 79
2021
Q3
$54.8M Buy
925,718
+86,195
+10% +$5.68M 0.27% 78
2021
Q2
$56.1M Buy
839,523
+105,089
+14% +$6.85M 0.31% 69
2021
Q1
$46.4M Buy
734,434
+82,553
+13% +$5.14M 0.3% 71
2020
Q4
$40.4M Buy
651,881
+35,088
+6% +$2.16M 0.31% 71
2020
Q3
$37.2M Buy
616,793
+94,718
+18% +$5.7M 0.34% 69
2020
Q2
$30.7M Buy
522,075
+41,647
+9% +$2.49M 0.35% 65
2020
Q1
$26.8M Sell
480,428
-7,901
-2% -$483K 0.41% 52
2019
Q4
$30.7M Buy
488,329
+187,753
+62% +$10.8M 0.4% 53
2019
Q3
$15.2M Buy
300,576
+11,439
+4% +$538K 0.25% 84
2019
Q2
$13.1M Buy
289,137
+69,497
+32% +$3.24M 0.22% 91
2019
Q1
$10.5M Buy
219,640
+14,380
+7% +$716K 0.22% 97
2018
Q4
$9.26M Sell
205,260
-30,375
-13% -$1.63M 0.23% 91
2018
Q3
$14.6M Sell
235,635
-4,521
-2% -$268K 0.3% 71
2018
Q2
$13.3M Buy
240,156
+11,422
+5% +$617K 0.29% 71
2018
Q1
$14.5M Sell
228,734
-21,344
-9% -$1.37M 0.34% 62
2017
Q4
$15.3M Buy
250,078
+3,527
+1% +$221K 0.33% 60
2017
Q3
$15.7M Buy
246,551
+6,380
+3% +$373K 0.37% 57
2017
Q2
$13.4M Sell
240,171
-28,339
-11% -$1.54M 0.33% 61
2017
Q1
$14.6M Buy
268,510
+5,001
+2% +$274K 0.33% 61
2016
Q4
$15.7M Sell
263,509
-1,925
-0.7% -$105K 0.38% 62
2016
Q3
$14.3M Buy
265,434
+15,988
+6% +$1.03M 0.36% 65
2016
Q2
$18.3M Buy
249,446
+6,882
+3% +$486K 0.48% 57
2016
Q1
$15.5M Buy
242,564
+21,178
+10% +$1.34M 0.42% 61
2015
Q4
$15.2M Buy
221,386
+12,708
+6% +$840K 0.44% 62
2015
Q3
$12.4M Sell
208,678
-771
-0.4% -$48.9K 0.39% 63
2015
Q2
$13.9M Sell
209,449
-13,151
-6% -$867K 0.43% 59
2015
Q1
$14.4M Sell
222,600
-12,729
-5% -$797K 0.42% 57
2014
Q4
$14M Sell
235,329
-45,775
-16% -$2.58M 0.43% 55
2014
Q3
$14.4M Sell
281,104
-64,022
-19% -$3.2M 0.43% 53
2014
Q2
$16.7M Sell
345,126
-4,617
-1% -$228K 0.43% 53
2014
Q1
$18.2M Buy
349,743
+16,665
+5% +$887K 0.48% 44
2013
Q4
$17.6M Sell
333,078
-68,523
-17% -$3.49M 0.5% 43
2013
Q3
$18.6M Buy
401,601
+22,801
+6% +$1M 0.48% 42
2013
Q2
$16.9M Buy
+378,800
New +$16.4M 0.48% 40

Other funds holding BMY

Mitsubishi UFJ Asset Management's BMY Position: Q1 2026 in Review

Mitsubishi UFJ Asset Management increased its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2026, buying an estimated $19.4M and bringing the position to 5,092,003 shares worth $309M. The position accounts for 0.21% of the portfolio, ranked #92.

Mitsubishi UFJ Asset Management first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Mitsubishi UFJ Asset Management held 5,092,003 shares of Bristol-Myers Squibb worth $309M as of Q1 2026.
  • Mitsubishi UFJ Asset Management bought 333,373 Bristol-Myers Squibb shares in Q1 2026, an estimated $19.4M.
  • Bristol-Myers Squibb made up 0.21% of Mitsubishi UFJ Asset Management's portfolio in Q1 2026, its #92 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q1 2026, filed 12 May 2026.